Investigational Site (421) — New York, New York

Investigational Site (421) is a clinical research site located in New York, New York, United States 10028.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site (421) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia.

Sponsors: Alpine Immune Sciences, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site (421)?

Investigational Site (421) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site (421) conducted?

Investigational Site (421) has 1 clinical trials on record, with 1 currently active. Their work covers Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia.

Is Investigational Site (421) accredited by Crixeo Health?

Investigational Site (421) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site (421)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.